CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field […]
Infinera’s Award-winning Optical Networking Solutions Recognized and Honored by 2024 Lightwave Innovation Reviews
SAN JOSE, Calif., March 04, 2024 (GLOBE NEWSWIRE) — Infinera (Nasdaq: INFN) announced today its industry-leading optical networking solutions have […]
Gorilla Technology Group and Lanner Electronics Inc. Forge Strategic Partnership to Develop AI-Enabled Cybersecurity Products in MENA Region
–New Partnership Enables Gorilla Technology Group to Expand on Already Significant Presence in the Middle-East and North Africa Region––Raises the […]
MIMEDX Announces Appointment of Two New Independent Directors
MARIETTA, Ga., March 04, 2024 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the […]
Auddia Updates Status of Overall M&A User Acquisition Strategy
All three acquisition targets in total would represent nearly 10 million monthly active users (MAUs), over $5M in annual revenue, […]
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused […]
Ventyx Biosciences to Host Virtual Investor Event on March 11, 2024
SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on […]
Vor Bio to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today […]
TeraWulf Announces February 2024 “Leap Month” Production and Operations Update
7.9 EH/s of installed and operational self-mining capacity Building 4 (35 MW) at Lake Mariner advancing construction, providing path to […]
4DMT to Participate in Upcoming Investor Conferences
EMERYVILLE, Calif., March 04, 2024 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic […]
